Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001176256-09-000252
Filing Date
2009-03-23
Accepted
2009-03-23 14:35:30
Documents
5
Period of Report
2009-03-23

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2008 - AMENDMENT NO. 1 angiotech10ka.htm 10-K/A 63806
2 DISCLOSURE INCORPORATED BY REFERENCE INTO PART II OF THIS ANNUAL REPORT ON FORM exhibit13.htm EX-13 978751
3 SECTION 302 CEO CERTIFICATION exhibit31-1.htm EX-31.1 7952
4 SECTION 302 CFO CERTIFICATION exhibit31-2.htm EX-31.2 8006
5 SECTION 906 CEO AND CFO CERTIFICATION exhibit32-1.htm EX-32.1 4734
  Complete submission text file 0001176256-09-000252.txt   1064510
Mailing Address
Business Address 1618 STATION STREET VANCOUVER A1 V6A 1B6
ANGIOTECH PHARMACEUTICALS INC (Filer) CIK: 0001096481 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-30334 | Film No.: 09698534
SIC: 2834 Pharmaceutical Preparations